Home Newsfeeds ONEOK Q2 EPS $0.92 Beats $0.90 Estimate

ONEOK Q2 EPS $0.92 Beats $0.90 Estimate

ONEOK (NYSE:OKE) reported quarterly earnings of $0.92 per share which beat the analyst consensus estimate of $0.90 by 2.22 percent. This is a 19.48 percent increase over earnings of $0.77 per share from the same period

byMichael Horton

August 8, 2022

1 minute read

Earnings

Earnings Preview: Broadridge Financial Soln

By Benzinga Insights

January 31, 11:02 AM

Broadridge Financial Soln (NYSE:BR) is set to give its latest quarterly earnings report on Thursday, 2024-02-01. Here’s what…

3 Rivian Analysts On Q2 Earnings: EV Production, Margins Shine, But Is ‘Cash Burn’ Ahead?

By AJ Fabino

August 9, 12:13 PM

3 Rivian analysts weigh in on Q2 earnings

RIVN

NGM Biopharmaceuticals Q3 EPS $(0.59) Down From $(0.37) YoY, Sales $7.91M Down From $18.57M YoY

By Benzinga Newsdesk

November 3, 5:24 PM

NGM Biopharmaceuticals (NASDAQ:NGM) reported quarterly losses of $(0.59) per share. This is a 59.46 percent decrease over losses of $(0.37) per share from the same period last year. The company reported $7.91 million in

NGM

Morgan Stanley Assumes Fifth Third Bancorp at Equal-Weight, Announces Price Target of $37

By Benzinga Newsdesk

December 5, 10:13 AM

Morgan Stanley analyst Manan Gosalia assumes Fifth Third Bancorp (NASDAQ:FITB) with a Equal-Weight rating and announces Price Target of $37.

FITB

ONEOK Q2 EPS $0.92 Beats $0.90 Estimate

Related Posts

Earnings Preview: Broadridge Financial Soln

3 Rivian Analysts On Q2 Earnings: EV Production, Margins Shine, But Is ‘Cash Burn’ Ahead?

NGM Biopharmaceuticals Q3 EPS $(0.59) Down From $(0.37) YoY, Sales $7.91M Down From $18.57M YoY

Morgan Stanley Assumes Fifth Third Bancorp at Equal-Weight, Announces Price Target of $37